Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. They are generally manufactured through a variety of processes that include chemical synthesis, fermentation processes, recombinant DNA, etc.

Microbial fermentation APIs are secondary metabolites produced by micro-organisms such as fungi and actinomycetes. The micro-organisms are capable of converting inexpensive carbon sources (starch, glucose, sucrose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into highly valuable API's or key intermediates (such as amino acids, vitamines, antibiotics) in liquid or solid media under certain growth conditions (nutrients, temperature, PH, oxygen supply).

Microorganisms that are typically used within the pharmaceutical industry include: prokaryotes such as Bacteria (e.g. Escherichia coli, Staphylococcus aureus) and Streptomycetes (e.g. Streptomyces spp, Actinomyces spp), eukaryotes such as Filamentous Fungi (e.g., Nigrospora spp, Aspergillus spp,) and Yeast (e.g. Saccharomyces cereviciae, Pichia pastoris).

With developed pharmaceuticals industry, Europe, USA and Japan are the major consumption markets of microbial fermentation APIs. These international pharmaceuticals giants generally purchase APIs from Asia, especially China and India.

China is the emerging consumption market of microbial fermentation APIs and it is also the largest supplier. In the market of antibiotics and vitamin, China have occupied market share of more than half. With foreign based plants and local manufacturers, India is another major supplier of APIs.

Antibiotics enjoyed the largest market share of microbial fermentation APIs, and China is the largest supplier with production of about 150 K MT. Amino acids are another important parts of microbial fermentation APIs market. Among these amino acids, the amount of glutamic acid and l-lysine are at most.

According to this study, over the next five years the Microbial Fermentation APIs market will register a 1.8% CAGR in terms of revenue, the global market size will reach US$ 30800 million by 2024, from US$ 27700 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Microbial Fermentation APIs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Microbial Fermentation APIs market by product type, application, key manufacturers and key regions and countries.

This study considers the Microbial Fermentation APIs value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

Antibiotics

Amino acids

Vitamin

Nucleotide

Organic acid

Alcohol

Biological products

Hormone

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Hospitals

Research & Academic Laboratories

Pharmaceutical & Biotechnology Companies

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Merck

Ajinomoto

HGPF

Huaxing

North China Pharmaceutical

Topfond

DSM

Tianyao

CSPC Pharma

Northeast Pharm

Lukang Pharmaceutical

Luwei Pharmaceutical

Jiangshan (DSM)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Microbial Fermentation APIs consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Microbial Fermentation APIs market by identifying its various subsegments.

Focuses on the key global Microbial Fermentation APIs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Microbial Fermentation APIs with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Microbial Fermentation APIs submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Microbial Fermentation APIs Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Microbial Fermentation APIs Consumption 2014-2024

2.1.2 Microbial Fermentation APIs Consumption CAGR by Region

2.2 Microbial Fermentation APIs Segment by Type

2.2.1 Antibiotics

2.2.2 Amino acids

2.2.3 Vitamin

2.2.4 Nucleotide

2.2.5 Organic acid

2.2.6 Alcohol

2.2.7 Biological products

2.2.8 Hormone

2.3 Microbial Fermentation APIs Consumption by Type

2.3.1 Global Microbial Fermentation APIs Consumption Market Share by Type (2014-2019)

2.3.2 Global Microbial Fermentation APIs Revenue and Market Share by Type (2014-2019)

2.3.3 Global Microbial Fermentation APIs Sale Price by Type (2014-2019)

2.4 Microbial Fermentation APIs Segment by Application

2.4.1 Hospitals

2.4.2 Research & Academic Laboratories

2.4.3 Pharmaceutical & Biotechnology Companies

2.5 Microbial Fermentation APIs Consumption by Application

2.5.1 Global Microbial Fermentation APIs Consumption Market Share by Application (2014-2019)

2.5.2 Global Microbial Fermentation APIs Value and Market Share by Application (2014-2019)

2.5.3 Global Microbial Fermentation APIs Sale Price by Application (2014-2019)

3 Global Microbial Fermentation APIs by Players

3.1 Global Microbial Fermentation APIs Sales Market Share by Players

3.1.1 Global Microbial Fermentation APIs Sales by Players (2017-2019)

3.1.2 Global Microbial Fermentation APIs Sales Market Share by Players (2017-2019)

3.2 Global Microbial Fermentation APIs Revenue Market Share by Players

3.2.1 Global Microbial Fermentation APIs Revenue by Players (2017-2019)

3.2.2 Global Microbial Fermentation APIs Revenue Market Share by Players (2017-2019)

3.3 Global Microbial Fermentation APIs Sale Price by Players

3.4 Global Microbial Fermentation APIs Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Microbial Fermentation APIs Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Microbial Fermentation APIs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Microbial Fermentation APIs by Regions

4.1 Microbial Fermentation APIs by Regions

4.1.1 Global Microbial Fermentation APIs Consumption by Regions

4.1.2 Global Microbial Fermentation APIs Value by Regions

4.2 Americas Microbial Fermentation APIs Consumption Growth

4.3 APAC Microbial Fermentation APIs Consumption Growth

4.4 Europe Microbial Fermentation APIs Consumption Growth

4.5 Middle East & Africa Microbial Fermentation APIs Consumption Growth

5 Americas

5.1 Americas Microbial Fermentation APIs Consumption by Countries

5.1.1 Americas Microbial Fermentation APIs Consumption by Countries (2014-2019)

5.1.2 Americas Microbial Fermentation APIs Value by Countries (2014-2019)

5.2 Americas Microbial Fermentation APIs Consumption by Type

5.3 Americas Microbial Fermentation APIs Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Microbial Fermentation APIs Consumption by Countries

6.1.1 APAC Microbial Fermentation APIs Consumption by Countries (2014-2019)

6.1.2 APAC Microbial Fermentation APIs Value by Countries (2014-2019)

6.2 APAC Microbial Fermentation APIs Consumption by Type

6.3 APAC Microbial Fermentation APIs Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Microbial Fermentation APIs by Countries

7.1.1 Europe Microbial Fermentation APIs Consumption by Countries (2014-2019)

7.1.2 Europe Microbial Fermentation APIs Value by Countries (2014-2019)

7.2 Europe Microbial Fermentation APIs Consumption by Type

7.3 Europe Microbial Fermentation APIs Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Microbial Fermentation APIs by Countries

8.1.1 Middle East & Africa Microbial Fermentation APIs Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Microbial Fermentation APIs Value by Countries (2014-2019)

8.2 Middle East & Africa Microbial Fermentation APIs Consumption by Type

8.3 Middle East & Africa Microbial Fermentation APIs Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Microbial Fermentation APIs Distributors

10.3 Microbial Fermentation APIs Customer

11 Global Microbial Fermentation APIs Market Forecast

11.1 Global Microbial Fermentation APIs Consumption Forecast (2019-2024)

11.2 Global Microbial Fermentation APIs Forecast by Regions

11.2.1 Global Microbial Fermentation APIs Forecast by Regions (2019-2024)

11.2.2 Global Microbial Fermentation APIs Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Microbial Fermentation APIs Forecast by Type

11.8 Global Microbial Fermentation APIs Forecast by Application

12 Key Players Analysis

12.1 Merck

12.1.1 Company Details

12.1.2 Microbial Fermentation APIs Product Offered

12.1.3 Merck Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 Merck News

12.2 Ajinomoto

12.2.1 Company Details

12.2.2 Microbial Fermentation APIs Product Offered

12.2.3 Ajinomoto Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 Ajinomoto News

12.3 HGPF

12.3.1 Company Details

12.3.2 Microbial Fermentation APIs Product Offered

12.3.3 HGPF Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 HGPF News

12.4 Huaxing

12.4.1 Company Details

12.4.2 Microbial Fermentation APIs Product Offered

12.4.3 Huaxing Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Huaxing News

12.5 North China Pharmaceutical

12.5.1 Company Details

12.5.2 Microbial Fermentation APIs Product Offered

12.5.3 North China Pharmaceutical Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 North China Pharmaceutical News

12.6 Topfond

12.6.1 Company Details

12.6.2 Microbial Fermentation APIs Product Offered

12.6.3 Topfond Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Topfond News

12.7 DSM

12.7.1 Company Details

12.7.2 Microbial Fermentation APIs Product Offered

12.7.3 DSM Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 DSM News

12.8 Tianyao

12.8.1 Company Details

12.8.2 Microbial Fermentation APIs Product Offered

12.8.3 Tianyao Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)

12.8.4 Main Business Overview

12.8.5 Tianyao News

12.9 CSPC Pharma

12.9.1 Company Details

12.9.2 Microbial Fermentation APIs Product Offered

12.9.3 CSPC Pharma Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)

12.9.4 Main Business Overview

12.9.5 CSPC Pharma News

12.10 Northeast Pharm

12.10.1 Company Details

12.10.2 Microbial Fermentation APIs Product Offered

12.10.3 Northeast Pharm Microbial Fermentation APIs Sales, Revenue, Price and Gross Margin (2017-2019)

12.10.4 Main Business Overview

12.10.5 Northeast Pharm News

12.11 Lukang Pharmaceutical

12.12 Luwei Pharmaceutical

12.13 Jiangshan (DSM)

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Microbial Fermentation APIs

Table Product Specifications of Microbial Fermentation APIs

Figure Microbial Fermentation APIs Report Years Consid